(Q35986621)

11 August 2017

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma (English)

1 reference

11 August 2017

1 reference

6

Chun-Ta Liao

1 reference

11 August 2017

Yin-Ping Hsu

1

1 reference

11 August 2017

Chia-Hsun Hsieh

2

1 reference

11 August 2017

Hui-Tzu Chien

3

1 reference

11 August 2017

Chi-Hsiung Lai

4

1 reference

11 August 2017

Chung-Kan Tsao

5

1 reference

11 August 2017

Chung-Jan Kang

7

1 reference

11 August 2017

Hung-Ming Wang

8

1 reference

11 August 2017

Joseph Tung-Chieh Chang

9

1 reference

11 August 2017

Shiang-Fu Huang

10

1 reference

11 August 2017

21 August 2015

1 reference

World Journal of Surgical Oncology

11 August 2017

1 reference

11 August 2017

13

1 reference

11 August 2017

253

1 reference

Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Diagnostic accuracy of Cyfra 21-1 for head and neck squamous cell carcinoma: a meta-analysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Cytokeratin fragments in the serum: their utility for the management of oral cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Epidemiology of non-steroidal anti-inflammatory drugs and cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

2 October 2017

Inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

The role of C-reactive protein as a prognostic indicator in advanced cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Inflammation and cancer: back to Virchow?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

A prospective study of serum C-reactive protein and colorectal cancer risk in men.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4546149

Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma

24 September 2018

1 reference

12 December 2020

A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients

1 reference

12 December 2020

Analysis of risk factors of predictive local tumor control in oral cavity cancer

1 reference

12 December 2020

Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection

1 reference

12 December 2020

Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC

1 reference

12 December 2020

Comparison of Cyfra 21-1 and SCC assays in head and neck tumours

1 reference

12 December 2020

Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels

1 reference

12 December 2020

Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma

1 reference

12 December 2020

Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer

1 reference

12 December 2020

Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma

1 reference

12 December 2020

Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma

1 reference

12 December 2020

Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma

1 reference

12 December 2020

Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN)

1 reference

12 December 2020

Lung Cancer-Associated Keratin 19 Fragments: Development and Biochemical Characterisation of the New Serum Assay Enzymun-Test® Cyfra 21–1

1 reference

12 December 2020

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

1 reference

12 December 2020

10.1186/S12957-015-0656-9

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

26292957

1 reference